ArticleClinical cancer research : an official journal of the American Association for Cancer Research2016

Parallel In Vivo Assessment of Drug Phenotypes at Various Time Points during Systemic BRAF Inhibition Reveals Tumor Adaptation and Altered Treatment Vulnerabilities.

Oliver Jonas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.